US Equities Analysis

MET — MetLife

MET MET Price Chart

MetLife (MET) is a life & health insurance company in the Financials sector. Listed on the NASDAQ, MetLife is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $86.13.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$86.13
Latest Date2026-06-10
Expected Return (Annualized)12.32%
Risk / Std Dev (Annualized)25.73%
Sharpe Ratio (rf=4.5%)0.30

S&P 500 Context

  • Sector: Financials
  • Sub-Industry: Life & Health Insurance
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of 12.32% with an annualized volatility of 25.73%. The Sharpe ratio of 0.30 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap55.42B
Enterprise Value77.75B
Trailing P/E16.66
Forward P/E7.83
Price to Book2.04
Price to Sales0.71
EV/Revenue1.0
EV/EBITDA13.08

| Profitability | | | Profit Margin | 4.67% | | Operating Margin | 9.92% | | ROE | 13.01% | | ROA | 0.45% |

| Growth | | | Revenue Growth | 2.7% | | Earnings Growth | 35.9% |

| Dividend | | | Dividend Yield | 275.0% | | Payout Ratio | 43.91% | | 5Y Avg Yield | 295.0% |

| Financial Health | | | Total Revenue | 77.58B | | Total Debt | 49.49B | | Total Cash | 27.63B | | Free Cash Flow | -17.43B | | Operating Cash Flow | 15.52B |

| Price & Technical | | | 52W High | $87.7$ | | 52W Low | $67.33$ | | 50-Day Avg | $78.58$ | | 200-Day Avg | $77.97$ | | Beta | 0.78 | | Shares Outstanding | 0.64B | | Float Shares | 0.54B | | Insider Holdings | 16.42% | | Institutional Holdings | 78.39% | | Short Ratio | 4.09 | | Short % of Float | 2.18% |

| Analyst Targets | | | Target High | $106.0$ | | Target Low | $75.0$ | | Target Mean | $92.0$ | | Target Median | $93.0$ | | # of Analysts | 16 | | Recommendation | buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity met financials life--health-insurance nasdaq